Improve Cancer-related Cognitive Impairment

Part of paid clinical trials in Birmingham, Alabama.

Sponsor
University of Alabama at Birmingham
Study ID
NCT05864274
Status
Recruiting

Conditions

  • Cancer-related Cognitive Difficulties
  • Chemo-brain
  • Chemotherapy Effect
  • Gynecologic Cancer

Eligibility Criteria

Sex
FEMALE
Age
18 Years - 90 Years
Healthy Volunteers
Accepted

Interventions

  • Cognitive training application — DEVICE
    Patients will participate with a cognitive training application and undergo neurocognitive testing during and after chemotherapy.

Study Details

Cancer-related cognitive impairment (CRCI), also known as "chemobrain," is the cognitive decline that negatively impacts the majority of cancer patients undergoing chemotherapy, radiation, and/or hormonal treatments. This application focuses on evaluating if using a cognitive mobile training application can decrease the impact of CRCI in gynecologic oncology patients through a multidisciplinary approach with patients undergoing assessments by our neurocognitive team.

Key Dates

Start date
Sep 1, 2024
Status verified
Nov 2025
Primary completion
Aug 1, 2027
Completion
Aug 1, 2027

Study Design

Enrollment
64 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • No Intervention: OBSERVATION
    PATIENTS WILL PARTICIPATE IN THE NEUROPSYCHOLOGY EVALUATION BUT WILL NOT USE THE COGNITIVE MOBILE TRAINING APPLICATION.
  • Experimental: MOBILE COGNITIVE TRAINING APP
    These patients will undergo neuropsychology evaluation and use the cognitive mobile training application

Primary Outcome Measure

Neurocognitive function [ Time Frame: From initiation of chemotherapy through 2 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Alabama at BirminghamBirminghamAlabama35233
Teresa KL Boitano, MD
205-934-0462

Find similar trials in Birmingham, AL

Related Studies